; cytisinicline and its other operations; the risk that cytisinicline may not receive regulatory approval or be successfully commercialized; the risk that Achieve may not be able to successfully market cytisinicline; the risk that new developments in the smoking cessation market may render cytisinicline uncompetitive or obsolete; the risk that Achieve may not be able to successfully develop new indications for cytisinicline; the risk that Achieve may not be able to achieve its goals and milestones in a timely manner or at all; the risk that Achieve may not be able to successfully implement its business strategies; the risk that Achieve\’s intellectual property may not be adequately protected; and the risk of potential litigation. Achieve undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Achieve Life Sciences, Inc. Media Contact
Glenn Silver
[email protected]
(646) 871-8485
Achieve Life Sciences, Inc. Investor Relations Contact
Jason Wong
[email protected]
(415) 375-3340
Sources:
1 Centers for Disease Control and Prevention. Adult Cigarette Smoking in the United States. Smoking & Tobacco Use. https://www.cdc.gov/tobacco/data_statistics/fact_sheets/adult_data/cig_smoking/index.htm
2 World Health Organization. WHO Report on the Global Tobacco Epidemic, 2021. Geneva, Switzerland: World Health Organization, 2021
3 Centers for Disease Control and Prevention. Health Effects of Cigarette Smoking. Smoking & Tobacco Use. https://www.cdc.gov/tobacco/data_statistics/fact_sheets/health_effects/effects_cig_smoking/index.htm
4 Centers for Disease Control and Prevention. Quick Facts on the Risks of E-cigarettes for Kids, Teens, and Young Adults. Smoking & Tobacco Use. https://www.cdc.gov/tobacco/basic_information/e-cigarettes/Quick-Facts-on-the-Risks-of-E-cigarettes-for-Kids-Teens-and-Young-Adults.html”